Titan Biotech Board Meeting Outcome

Titan Biotech Q2 FY27 Results: Net Profit ₹12.5 Cr, Up 60.3% YoY

Titan Biotech Ltd reported revenue from operations of ₹76.5 Cr (+40.6% YoY) and net profit of ₹12.5 Cr (+60.3% YoY) for Q2 FY27.

Key figure

Net profit ₹12.5 Cr · +60.3% YoY

Titan Biotech Board Meeting Date

Titan Biotech's board meets 05 November 2026 to consider unaudited quarterly and half-year results. Trading window stays closed until 48 hours after outcome declaration.

Titan Biotech Bonus Issue

Titan Biotech allotted 1,03,29,625 bonus shares of Rs. 2 each in a 1:4 ratio. Paid-up capital rose to Rs. 10.33 Crore post-allotment.

Titan Biotech Other Announcement

Titan Biotech Limited has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.

Titan Biotech Bonus Issue

Titan Biotech Ltd fixed October 23, 2026, as the record date for its 1:4 bonus share issue. Allotment is scheduled for October 26, 2026.

Titan Biotech Capital Structure Change

Titan Biotech increased its authorised share capital from Rs. 10 Crore to Rs. 10.40 Crore, following shareholder approval at the 34th Annual General Meeting.

Balmer Lawrie Investments Board Meeting Outcome

Balmer Lawrie Investments appointed M/s. K. K. Chanani & Associates as Statutory Auditor for FY 2026-27 under Section 139(5), per a C&AG letter. The appointment is effective from 10 November 2026.

Execution

FY 2026-27

Jiwanram Sheoduttrai Industries Board Meeting Outcome

Jiwanram Sheoduttrai's board approved convening its 29th AGM on 30 November 2026 and re-appointing a retiring non-executive director. The board also approved the FY2025-26 Board's Report.

Finolex Cables Board Meeting Outcome

Finolex Cables' board approved amending its insider trading code of conduct on 7 November 2026. Amended code was filed under PIT Regulation 8(2).

Chatterbox Technologies Board Meeting Outcome

Chatterbox's board approved a Rs. 7 crore related-party ceiling with its UAE subsidiary and a vendor change for IPO funds. Monitoring agency and deviation reports were also noted.

BCC Fuba India Board Meeting Outcome

BCC Fuba India's board met on November 6, 2026 and took note of consolidated related party transactions for the half year ended September 30, 2026. No financial results, capital raise or other material decision was reported.

Voltas Board Meeting Outcome

Voltas Limited's board approved Deloitte Haskins & Sells as statutory auditors for five years from the 73rd AGM, replacing SRBC & Co. LLP, whose second and final term ends at that AGM. Subject to shareholder approval.

Execution

Five years: financial years 2027-28 to 2031-32 (from the 73rd AGM in 2027 to the 78th AGM in 2032)